ERα is also expressed in prostate CAFs, however, clinical implications remain unclear with some reports identifying CAF ERα and ERβ expression as a marker of clinically advanced disease [50], while other reports suggest ERα expressing CAFs provide a protective effect against tumor cell invasion and macrophage infiltration [69,70]. This evidence concerns the gene ESR1 and neoplasm.